 |
|
|
| |
Characterization of the resistance profile of TMC278:
48-week analysis of the Phase III studies ECHO and THRIVE
|
| |
| |
Reported by Jules Levin
ICAAC Boston Sept 14 2010
L Rimsky,1 J Eron,2 B Clotet,3 J Vingerhoets,1 S Vanveggel,1
M Stevens,1 K Boven,4 and G Picchio4
1Tibotec, Beerse, Belgium; 2University of North Carolina, Chapel Hill, NC, USA;
3irsiCaixa Foundation, Barcelona, Spain; 4Tibotec, NJ, USA
|
| |
|
|
|
|
|
